FABP3 and cardiomyopathy: Patients with high levels of H-FABP are exposed to increased risk of death and cardiomyopathies; Troponin T, BNP and NT-pro-BNP are established biomarkers of cardiotoxicity induced by anthracyclines, immune checkpoint inhibitors and radiotherapy (47, 48).